Table 11.
EPIAO®/EPREX® treatment for 12 mo and baseline wkly epoetin dosage (IU/kg).
| EPIAO® (N = 68) | EPREX® (N = 69) | P value | 95% CI | |||||
|---|---|---|---|---|---|---|---|---|
| Index | Baseline | 12 mo | Difference | Baseline | 12 mo | Difference | Confidence interval | |
| Dosage of wkly epoetin (IU/kg) | ||||||||
| Mean (SD) | 92.17 (54.92) | 69.59 (64.91) | −22.57 (59.64) | 113.88 (57.45) | 90.72 (63.3) | −23.15 (55.85) | ||
| Median (Q1~Q3) | 86.25 (55.59~113.43) |
52.16 (25.85~90.76) |
−21.3 (−44.58~7.34) |
100.4 (68.66~144.13) |
81.63 (38.1~120.6) |
−20.08 (−68.05~14.78) |
||
| Min~Max | 18.21~329.67 | 0~351.65 | −244.9~202.27 | 30.3~277.78 | 0~290.91 | −164.63~98.68 | ||
| Wkly epoetin dosage (IU/kg) difference | .47 | −6.8 (−25.59, 11.98) | ||||||